compound 28

Compound 28 (mTOR inhibitor WYE-28) is a selective inhibitor of mTOR (IC50=0.08 nM). Also inhibits PI3Kα (IC50 6 nM).

sn-Glycero-3-phosphocholine (Choline glycerophosphate) is a natural choline compound found in the brain and in milk. It is also a parasympathomimetic acetylcholine precursor which may have a potential for the treatment of Alzheimer's disease and dementia. sn-Glycero-3-phosphocholine rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of the acetylcholine neurotransmitter. It is a non-prescription drug in most countries due to its Generally Recognised As Safe (GRAS) status [1]. Studies have investigated its efficacy for cognitive disorders including stroke and Alzheimer's disease. An Italian multicentre clinical trial on 2, 044 patients suffering from recent stroke were supplied Glycerylphosphorylcholine in doses of 1, 000 mg day for 28 days and 400 mg three times per day for the five ensuing months. The trial confirmed the therapeutic role of alpha-GPC on the cognitive recovery of patients based on four measurement scales, three of which reached statistical significance [2].

Catharantin; Catharanthine is a useful organic compound for research related to life sciences. The catalog number is T123890 and the CAS number is 94444-28-7.

Glycoside L-B is a useful organic compound for research related to life sciences. The catalog number is T124399 and the CAS number is 68579-28-2.

Abbeokutone is a useful organic compound for research related to life sciences. The catalog number is T125620 and the CAS number is 16836-28-5.

Palitantin is a useful organic compound for research related to life sciences. The catalog number is T125757 and the CAS number is 15265-28-8.

Chebuloside II is a useful organic compound for research related to life sciences. The catalog number is T125795 and the CAS number is 149475-28-5.

Longilactone, delta-4(18)-Isomer, 2alpha-alcoho is a useful organic compound for research related to life sciences. The catalog number is T125797 and the CAS number is 149155-28-2.

4-Phenyl-3-(phenylmethyl)-2(5H)-furanone is a useful organic compound for research related to life sciences. The catalog number is T125831 and the CAS number is 146140-28-5.

Clopidogrel Related Compound A is a useful organic compound for research related to life sciences. The catalog number is T125853 and the CAS number is 144457-28-3.

6-Hydroxy-3-oxo-20(29)-lupen-28-oic acid is a useful organic compound for research related to life sciences. The catalog number is T126463 and the CAS number is 106327-33-7.

VDR agonist 1 (compound 28), a nonsteroidal Vitamin D receptor (VDR) agonist, demonstrates potent activity with a low IC 50 of 690 nM in MCF-7 cells. It inhibits cell cycle progression through upregulation of p21 and p27, and induces apoptosis by elevating BAX expression while reducing Bcl-2 levels [1].

MEK RAF-IN-1 (Compound 16b) serves as an inhibitor targeting both MEK and RAF, demonstrating potent efficacy with IC 50 values reported at 28 nM for MEK1, and 3 nM for both BRAF and BRAFV600E. This compound exhibits significant antitumor capabilities, effectively curbing cell proliferation in vitro in MIA PaCa-2 (G12C KRAS), HCT116 (G13D KRAS), and C26 (G12D KRAS) cells. Furthermore, MEK RAF-IN-1 significantly restricts tumor growth in xenograft mouse models employed in the study of colorectal cancer.

Apoptosisinducer 28 (Compound X1) is an apoptosis inducer with demonstrated in vitro anticancer activity. It arrests the cell cycle at the G1 phase, promoting cell death and inducing apoptosis by disrupting the mitochondrial membrane potential.

Neuroprotective agent 5 (compound 28) acts as a brain-penetrating agent with anti-neuroinflammatory, antioxidant, and neuroprotective properties. It exhibits potent inhibition of nitric oxide (NO) with an EC50 of 0.49 μM and suppresses the release of pro-inflammatory mediators PGE2 and TNF-α. Additionally, it downregulates the expression of iNOS and COX-2 proteins, facilitating the polarization of BV-2 cells from a pro-inflammatory M1 phenotype to an anti-inflammatory M2 phenotype. Neuroprotective agent 5 also dose-dependently inhibits acetylcholinesterase (AChE) activity and the aggregation of Aβ42. This compound is useful for research into Alzheimer's disease.

3-Acetyl-28-N–(3–guanidinobutoxy)-oleanolic acid (compound J1) serves as an effective antimicrobial agent, displaying activity against both Gram-positive bacteria and fungi. In addition to its primary use, it can also function as an adjuvant in antibiotic treatments. The mechanism of action for compound J1 involves disrupting bacterial cell membranes, integrating into DNA, and binding with DNA gyrase. Furthermore, it has been shown to reduce microbial counts and accelerate wound healing in a mouse MRSA skin infection model.

EGFR-IN-128 (compound 28) is a potent and selective molecule targeting wild-type EGFREx20Ins, demonstrating therapeutic efficacy across various human xenograft models and capable of penetrating the blood-brain barrier in preclinical species.

SARS-CoV-2 Mpro-IN-28 (Compound 1K) is an inhibitor of SARS-CoV-2 Mpro, exhibiting an EC50 of 24 μM.

αvβ6-IN-1 (compound 28) is an effective orally active inhibitor of αvβ6 integrin (αvβ6integrin), with a pIC50 value of 8.1. This compound shows potential for research in idiopathic pulmonary fibrosis.

PROTAC SMARCA2 degrader-28 (Compound 158) is a potent SMARCA2 PROTAC degrader that achieves degradation of SMARCA2 in HiBiT A549 cells, exhibiting a DC50 of 3 nM.

ATRkinase-IN-3 (Compound I-G-28) is an inhibitor of the ATR protein kinase, exhibiting a Ki value ranging from 0.01 to 1 μM, and is utilized in cancer research.

GuaB-IN-1 (Compound 15) is effective against M.tb with a MIC value of 0.25 μM. At a concentration of 10 μM, GuaB-IN-1 exhibits a 28% inhibition of hERG. This compound holds promise for tuberculosis research.

RET-IN-28 (Compound 16) is an inhibitor of RET (a transmembrane receptor tyrosine kinase). It specifically inhibits the activity of a mutant RET enzyme (RET-V804M) and is utilized in cancer research.

FGFR1inhibitor-14 (compound 28) is an FGFR1 inhibitor used in cancer research.